Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Net Margin Over TimeContracting
Percentile Rank38
3Y CAGR-19.8%
5Y CAGR-15.4%
Studio
Year-over-Year Change

Net income as a percentage of revenue

3Y CAGR
-19.8%/yr
vs -4.2%/yr prior
5Y CAGR
-15.4%/yr
Recent deceleration
Acceleration
-15.6pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM13.01%-37.1%
202420.70%-5.9%
202322.00%-12.8%
202225.24%-17.9%
202130.74%+2.6%
202029.96%-2.5%
201930.73%+2.4%
201830.01%-63.0%
201781.11%+710.3%
201610.01%-